Skip to content

Clinical trials

Phase 3 Adenocarcinoma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 3 Country / region: Singapore Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20102
20142
20162
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott1
Ariad Pharmaceuticals1
Celgene1
Daiichi Sankyo1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Imunon1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma8
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasms4
Neoplasms by Site4
Carcinoma3
Neoplasms by Histologic Type3
Neoplasms, Glandular and Epithelial3
Carcinoma, Hepatocellular2
Carcinoma, Large Cell2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.